checkAd

     517  0 Kommentare DBV Technologies Announces Publication of Positive Viaskin Peanut Data From NIAID-Sponsored Phase II Academic Study in the Journal of Allergy and Clinical Immunology - Seite 3

    DBV Technologies Contact
    Susanna Mesa
    Senior Vice President, Strategy
    +1 212-271-0861
    susanna.mesa@dbv-technologies.com

    Media Contact
    Erinn White, Centron PR
    +1-646-722-8822
    ewhite@centronpr.com

    Lesen Sie auch

    Media Contact Europe
    Caroline Carmagnol, Alize RP, Relations Presse
    +33 (0)6 64 18 99 59 
    caroline@alizerp.com



    This announcement is distributed by Nasdaq Corporate Solutions on behalf of Nasdaq Corporate Solutions clients.
    The issuer of this announcement warrants that they are solely responsible for the content, accuracy and originality of the information contained therein.
    Source: DBV Technologies via Globenewswire
    Seite 3 von 3



    GlobeNewswire
    0 Follower
    Autor folgen
    RSS-Feed abonnieren

    Verfasst von GlobeNewswire
    1 im Artikel enthaltener WertIm Artikel enthaltene Werte
    DBV Technologies Announces Publication of Positive Viaskin Peanut Data From NIAID-Sponsored Phase II Academic Study in the Journal of Allergy and Clinical Immunology - Seite 3 Press ReleaseMontrouge, France, October 26, 2016 DBV Technologies Announces Publication of Positive Viaskin Peanut Data From NIAID-Sponsored Phase II Academic Study in the Journal of Allergy and Clinical Immunology The study, CoFAR6, evaluated …